— Know what they know.
Not Investment Advice
Also trades as: KOPRAN.BO (BSE) · $vol 0M

KOPRAN.NS NSE

Kopran Limited
1W: +4.2% 1M: +29.6% 3M: +45.9% YTD: +97.4% 1Y: +81.7% 3Y: +33.8% 5Y: +39.4%
₹282.95 ($2.94)
+4.63 (+1.66%)
 
NSE · Healthcare · Drug Manufacturers - General · Tech Score Buy · Power 71 · ₹13.7B mcap · 23M float · 3.96% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap₹13.7B ($141.9M)
52W Range107-295.83
Volume713,974
Avg Volume894,627
Beta0.86
Dividend₹3.00
Analyst Ratings
No analyst coverage
Company Info
CEOSurendra Shrikrishna Somani
Employees1,156
SectorHealthcare
IndustryDrug Manufacturers - General
IPO Date2002-07-01
Websitekopran.com
Parijat House
Mumbai, MA 400018
IN
91 22 4366 1111
About Kopran Limited

Kopran Limited is a fully integrated pharmaceutical entity that manufactures and distributes both active pharmaceutical ingredients (APIs) and finished drug products, serving markets in India and worldwide. Its extensive product portfolio includes a diverse array of dosage formats, such as tablets, capsules, dry powders, suspensions, and injectable solutions. The company's active pharmaceutical ingredients cater to a broad spectrum of therapeutic applications, encompassing macrolides, antibacterials, anticonvulsants, anti-hypertensives, anti-helminthics, antihistamines, anti-acne treatments, anti-infectives, urologicals, anti-thrombotics, antidiabetics, pain management, gastroenterology, and cardiovascular medications. Established in 1958, Kopran Limited maintains its corporate headquarters in Mumbai, India.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms